-
1
-
-
34249666052
-
Rationale and public health implications of changing CHD risk factor definitions
-
DOI 10.1146/annurev.publhealth.28.021406.144141
-
Kaplan R.M. Ong M. Rationale and public health implications of changing CHD risk factor definitions Annual Review of Public Health 2007 28 321-344 DOI 10.1146/annurev.publhealth.28.021406.144141 1 Kaplan R, Ong M. Rationale and public health implications of changing CHD risk factor definitions. Annu Rev Public Health 2007;28:321-44. (Pubitemid 46833346)
-
(2007)
Annual Review of Public Health
, vol.28
, pp. 321-344
-
-
Kaplan, R.M.1
Ong, M.2
-
3
-
-
84858996721
-
Are we at risk of being at risk?
-
Godlee F. Are we at risk of being at risk? BMJ 2010;341:c4766.
-
(2010)
BMJ
, vol.341
-
-
Godlee, F.1
-
4
-
-
0347423198
-
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
-
DOI 10.1161/01.HYP.0000107251.49515.c2
-
Chobanian A.V. Bakris G.L. Black H.R. Cushman W.C. Green L.A. Izzo J.L. Jr. Jones D.W. Materson B.J. Oparil S. Wright J.T. Jr. Roccella E.J. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 2003 42 6 1206-1252 DOI 10.1161/01.HYP.0000107251.49515.c2 4 Chobanian A, Bakris G, Black H, Cushman W, Green LA, Izzo JL Jr, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42:1206-52. (Pubitemid 37553153)
-
(2003)
Hypertension
, vol.42
, Issue.6
, pp. 1206-1252
-
-
Chobanian, A.V.1
Bakris, G.L.2
Black, H.R.3
Cushman, W.C.4
Green, L.A.5
Izzo Jr., J.L.6
Jones, D.W.7
Materson, B.J.8
Oparil, S.9
Wright Jr., J.T.10
Roccella, E.J.11
-
5
-
-
77956990248
-
Who benefits from treating prehypertension?
-
Moynihan R. Who benefits from treating prehypertension? BMJ 2010;341:c4442
-
(2010)
BMJ
, vol.341
-
-
Moynihan, R.1
-
6
-
-
75549091263
-
Statement by an American Association of Clinical Endocrinologists/ American College of Endocrinology consensus panel on type 2 diabetes mellitus: An algorithm for glycemic control
-
Rodbard H, Jellinger P, Davidson J, Einhorn D, Garber AJ, Grunberger G, et al. Statement by an American Association of Clinical Endocrinologists/ American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control Endocr Pract 2009;15:540-59
-
(2009)
Endocr Pract
, vol.15
, pp. 540-559
-
-
Rodbard, H.1
Jellinger, P.2
Davidson, J.3
Einhorn, D.4
Garber, A.J.5
Grunberger, G.6
-
7
-
-
61549090011
-
Validation of the Decreased Sexual Desire Screener (DSDS): A brief diagnostic instrument for generalised acquired female hypoactive sexual desire disorder (HSDD)
-
published online 13 January
-
Clayton, A, Goldfischer E, Goldstein I, Derogatis L, Lewis-D'Agostino DJ, Pyke R. Validation of the Decreased Sexual Desire Screener (DSDS): a brief diagnostic instrument for generalised acquired female hypoactive sexual desire disorder (HSDD). J Sexual Med 2009, published online 13 January.
-
(2009)
J Sexual Med
-
-
Clayton, A.1
Goldfischer, E.2
Goldstein, I.3
Derogatis, L.4
Lewis-D'Agostino, D.J.5
Pyke, R.6
-
8
-
-
77952094738
-
The DSM diagnostic criteria for hypoactive sexual desire disorder in women
-
published online 24 September
-
Brotto L. The DSM diagnostic criteria for hypoactive sexual desire disorder in women. Arch Sexual Behav 2009, published online 24 September.
-
(2009)
Arch Sexual Behav
-
-
Brotto, L.1
-
10
-
-
65649098320
-
Developing unbiased diagnostic and treatment guidelines in psychiatry
-
letter
-
Cosgrove L, Bursztajn H, Krimsky S. Developing unbiased diagnostic and treatment guidelines in psychiatry (letter). N Engl J Med 2009 360;19:2035-6.
-
(2009)
N Engl J Med
, vol.360
, Issue.19
, pp. 2035-2036
-
-
Cosgrove, L.1
Bursztajn, H.2
Krimsky, S.3
-
11
-
-
77749306403
-
The first draft of DSM-V
-
Frances A. The first draft of DSM-V. BMJ 2010;340:c1168
-
(2010)
BMJ
, vol.340
-
-
Frances, A.1
-
12
-
-
84859009440
-
-
US Department of Health and Human Services Food and Drug Administration. FDA guidance. 2008. www.fda.gov/downloads/RegulatoryInformation/Guidances/ UCM125646.pdf.
-
(2008)
FDA Guidance
-
-
-
14
-
-
77958047126
-
Intensified glucose lowering in type 2 diabetes: Time for a reappraisal
-
Yudkin JS, Richter B, Gale EA. Intensified glucose lowering in type 2 diabetes: time for a reappraisal. Diabetologia 2010;53:2079-85.
-
(2010)
Diabetologia
, vol.53
, pp. 2079-2085
-
-
Yudkin, J.S.1
Richter, B.2
Gale, E.A.3
-
15
-
-
84858998419
-
Diagnosis and management of ductal carcinoma in situ (DCIS)
-
NIH State of the Science Conference. Diagnosis and management of ductal carcinoma in situ (DCIS). 2009. http://consensus.nih.gov/2009/dcisstatement.htm.
-
(2009)
NIH State of the Science Conference
-
-
-
18
-
-
77649254579
-
Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy
-
International Association of Diabetes and Pregnancy Study Groups
-
International Association of Diabetes and Pregnancy Study Groups. Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy. Diabetes Care 2010;33:676-82.
-
(2010)
Diabetes Care
, vol.33
, pp. 676-682
-
-
|